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Abstract
In vivo spin spin relaxation time (T2) heterogeneity of hyper-
polarized 13C urea in the rat kidney was investigated. Selec-
tive quenching of the vascular hyperpolarized 13C signal with a
macromolecular relaxation agent revealed that a long-T2 compo-
nent of the 13C urea signal originated from the renal extravascular
space, thus allowing the vascular and renal filtrate contrast agent
pools of the 13C urea to be distinguished via multi-exponential
analysis. The T2 response to induced diuresis and antidiuresis
was performed with two imaging agents: hyperpolarized 13C urea
and a control agent hyperpolarized bis-1,1-(hydroxymethyl)-1-13C-
cyclopropane-2H8. Large T2 increases in the inner-medullar and
papilla were observed with the former agent and not the latter
during antidiuresis suggesting that T2 relaxometry may be used to
monitor the inner-medullary urea transporter (UT)-A1 and UT-A3
mediated urea concentrating process. Two high resolution imaging
techniques - multiple echo time averaging and ultra-long echo time
sub-2 mm3 resolution 3D imaging - were developed to exploit the
particularly long relaxation times observed.
Introduction
Urea is primary end product of nitrogen metabolism in mam-
mals, and humans typically produce more than 20 g of urea per
day [22]. Concentrating urea to more than 100 times plasma levels
for efficient excretion of this large osmotic load while minimiz-
ing water loss is one of the primary functions of the mammalian
kidney [3, 13, 49, 64]. Renal urea handling is a multistep process
beginning with filtration of the blood at the glomerulus followed
by a countercurrent multiplication in the medulla. The counter-
current exchange is assisted by urea transporters (UT) expressed
in the descending thin limb of the loops of Henle (UT-A2 iso-
form), the erythrocytes (UT-B isoform), and the inner two thirds
of the inner medullary collecting ducts (UT-A1 and UT-A3 iso-
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forms) [12,13,64,77]. The inner medullary collecting duct (IMDC)
transporters UT-A1 and UT-A3 increase the effective permeability
of the tubular wall in the presence of vasopressin. This allows for
urea to freely pass into the inner medullary interstitial fluid (IF)
where it can accumulate to greater than 1 M concentration when
water conservation is important.
Imaging renal solute handling could be a potentially valuable
tool for the study of renal function. Several magnetic resonance
imaging (MRI) studies have demonstrated non-invasive sodium de-
tection with 23Na-detected MRI [47, 48]. Indirect urea detection
via changes in the 1H water resonance after radio frequency (RF)
saturation of the urea amide frequency has been demonstrated
[11]. Direct magnetic resonance imaging (MRI) of intravenously-
injected 13C-labeled urea [16, 54, 56, 72, 73] and numerous other
small molecules [9, 18, 19, 21, 30–33, 43, 50, 70] has recently been
enabled using dynamic nuclear polarization (DNP) [2]. In this
process, the isotopically-enriched molecule is doped with an or-
ganic radical, cooled to liquid helium temperatures, and irradi-
ated at microwave frequencies to achieve polarizations many or-
ders of magnitude above thermal equilibrium values. After dissolu-
tion, the polarization decays exponentially with a time constant T1
which is typically on the order of 10-90 s for 13C-labeled carbonyl
sites [5,32]. This method has been utilized to generate background-
free angiograms in preclinical models using highly biocompatible
contrast agents [16,17].
Recently, a method for in vivo imaging of hyperpolarized 13C
urea with improved spatial resolution was presented which used
a T2-weighted steady state free precession (SSFP) sequence in
combination with supplementary 15N labeling of the urea amide
groups [62]. T2 mapping experiments performed in Sprague Dawley
rats gave uniform urea T2 values of approximately 1 s throughout
the animal with the exception of the kidneys, where values be-
tween 4 s and 15 s were noted [62]. Given the importance if urea
in renal solute handling process as well as the paucity of literature
discussing the physiological significance of in vivo 13C T2 contrast,
this current study presents measurements for further investigation
of the 13C urea T2 heterogeneity. In the first set of experiments, a
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chase infusion of an intravascular macromolecular relaxation agent
was performed after hyperpolarized 13C urea injection but prior
to T2 measurement. This experiment was designed to selectively
quench the vascular 13C urea signal while monitoring its effects
on the 13C T2 signal decay. A multi-exponential fitting algorithm
tracked the changes in signal intensity of the short- and long-T2
components both with and without the macromolecular relaxation
agent. In a second set of experiments, hyperpolarized 13C T2
mapping experiments were performed on rats on induced antid-
iuresis and osmotic diuresis with two imaging agents: hyperpolar-
ized 13C urea and hyperpolarized bis-1,1-(hydroxymethyl)-1-13C-
cyclopropane-2H8 (commonly abbreviated as HMCP or HP001).
In the antidiuresis state, the kidneys are in water conservation
mode, and the inner medullary transporters UT-A1 and UT-A3
aid to maximally concentrate urea in the inner medulla.
Materials and Methods
Animal Handling
Animal studies were performed under a protocol approved by the
University of California San Francisco Institutional Animal Care
and Utilization Committee (IACUC). Sprague Dawley rats (mean
mass 400 g) were anesthetized with a 1.7% isofluorane / oxygen
mixture under a constant flow rate of 1 liter per minute. Animals
were imaged in the supine position inside the birdcage coil and
thermally insulated via heat pad. Contrast agents were injected via
lateral tail vain catheters. Rats were housed three per cage at the
UCSF Laboratory Animal Resource Center (LARC). Experiments
were conducted between the hours of 5 p.m. and 1 a.m.
Hardware
Imaging experiments were conducted in a GE 3T clinical MRI (GE
Medical Systems, Waukesha, WI) equipped with a rat-sized dual-
tuned 1H / 13C transceiver birdcage RF coil (8 cm inner diameter)
placed on the patient table. An Oxford Instruments Hypersense
polarizer (Oxford Instruments, Oxford, UK) was used for dissolu-
tion DNP experiments.
Sample Preparation
Isotopically enriched [13C,15N2]urea and bis-1,1-(hydroxy-
methyl)-1-13C-cyclopropane-2H8 were each doped with the trityl
radical OX063 (Oxford Instruments, Abingdon, UK) and Dotarem
(Guerbet, Roissy, France) as described previously [62, 70, 71].
Supplementary urea 15N labeling was necessary for the T2 in-
crease afforded by the elimination of the scalar coupling of the
second kind relaxation pathway [7, 62]. Bovine serum albumin
(BSA) conjugated with an average of 23 gadolinium / diethylene
triamine pentaacetic acid (GdDTPA) chelates per BSA molecule
(abbreviated BSA-GdDTPA, molecular weight ∼ 85 kDa) was
synthesized using methods previously described [10,53].
13C MRI Acquisition
T2 mapping
13C T2 mapping was performed using sequences
previously described [62]. Dynamic projection images were ac-
quired in the coronal plane with 1 mm in-plane resolution, 14× 7
Figure 1: The hyperpolarized 13C T2 mapping experiment.
Hyperpolarized 13C-labeled substrates were injected via lateral tail
vain catheter inside the MRI scanner. The T2 mapping sequence
acquired coronal projection images at 0.9 s echo time intervals
while playing 180◦ pulses for 18 s. Each image was then corrected
for respiratory motion via rigid translation in the superior / inferior
direction. The dynamic images were then denoised using an SVD-
based thresholding in the space / time dimensions. The signal
component at each T2 was estimated using a regularized version
of the T2 non-negative least squares method, and the long and
short T2 signal components were isolated by integrating the T2
distribution.
cm FOV , 13 ms TR, and 70 phase encodes per image giving a
temporal resolution of 910 ms and 18.2 s total acquisition time for
all 20 echoes. Images were reconstructed with a simple 2D Fourier
transform without spatial filtering.
Relaxometric Data Analysis
Motion correction Periodic respiratory motion caused a 1-2
mm offset which was largely resolved along the superior / inferior
(SI) axis of the animal. This motion can be seen in the supple-
mentary videos S1 and S2. To correct for this observed shift, a
simple search algorithm was developed in which each image was
aligned with its previous time point. Given that the motion was
primarily 1D, a brute-force search was implemented which trans-
lated each image in 1 mm increments over ±1 cm from the initial
location along the SI axis (for a total of 20 sampling points). At
each position, the normalized mutual information (MI) was calcu-
2
lated between the floating image and the previous time point thus
generating an MI versus translation curve as shown in Fig 1. The
shift which maximized this curve was then applied.
Subspace Denoising Outside of the kidneys, the majority of
the 13C signal disappeared after the first few echoes (Fig 1). This
led to low rank data matrices in the spatiotemporal dimensions.
A singular value decomposition (SVD)-based denoising [27] could
therefore be utilized to better condition the ill-posed problem of
multi-exponential estimation [20, 59, 60, 75]. The 3-dimensional
images (x, y, t) were concatenated along the x and y dimensions
forming the matrix I(r, t). Singular values less than the largest 7
(out of 20) were set to zero. This SVD-thresholded matrix was
then used for the regularized T2 estimation (Fig 1).
Multi-Exponential Analysis The T2 non-negative least
squares (T2NNLS) algorithm [75] was used for quantitative anal-
ysis of the time-decay data. This method uses a least-squares
inversion with non-negativity constraints to estimate s(T2), the
signal’s T2 distribution at each pixel. T2NNLS is appealing since
it requires no a priori assumptions on the number of decay-modes.
However, regularization, necessary for management of noise am-
plification, imposes assumptions of the shape of the distribution.
L2 norm regularization produces smoothly varying distributions,
whereas L1 norm regularization generates a sparse T2 spectra [75].
We observed similar image appearance when using L1- and L2-
regularized inversion of separation of short- and long-T2 signal
components, but the sparse T2 spectra was easier to interpret vi-
sually (for example, see Fig. 3d). The inverse problem with L1
constraints minimized
||As− y||2 + λ||s||1, (1)
where the matrix A has the elements
Ai,j = e
−tj/T2,i . (2)
T2,i is an array of 128 logarithmically-spaced T2 values ranging
from .3 to 20 s, tj are the echo times (20 regularly spaced from 0.5
to 19 s), and yj is the detected pixel SNR values of the jth echo.
The regularization parameter λ was chosen to be 0.01% of λmax,
where λmax the maximum possible value for which the solution is
non-zero: λmax = 2 max
(
AT y
)
[36].
From the distribution s(T2), the signal sα,β in the range T2 ∈
[α, β] was calculated by integrating the s(T2) from α to β. A mean
〈T2〉 measure in the range T2 ∈ [α, β] was estimated by the first
moment of the distribution:
〈T2〉 = exp
{∫ β
α
s(T2) log T2 dT2∫ β
α
s(T2) dT2
}
. (3)
The integration limits α and β were used to isolate short- or long-
T2 species.
13C Urea / BSA-GdDTPA Relaxometry
13C Imaging Experiments These experiments were designed
to selectively quench the vascular 13C urea polarization while mea-
suring the differential attenuation of the short and long T2 signal
components. Analogous to previously reported experiments [69],
a gadolinium (Gd) carrier molecule was infused after the hyperpo-
larized 13C injection but prior to 13C detection. The paramagnetic
Gd greatly reduces the T1 of the
13C molecule thus causing rapid
13C polarization loss in regions where the 13C-labeled molecule and
the Gd carrier are in close proximity. This polarization loss mani-
fests as lowered signal during 13C imaging. This study used bovine
serum albumin as the carrier which was conjugated with and aver-
age of 23 Gd / diethylene triamine pentaacetic acid chelates (abbre-
viated BSA-GdDTPA). This a well-characterized blood pool agent
has a high molecular weight (85 kDa) which prohibits extravasa-
tion and glomerular filtration on the sub minute timescale [10,53].
To estimate the efficacy of hyperpolarized 13C signal quench-
ing, the 13C T1 relaxivity of [
13C,15N2]urea with respect to BSA-
GdDTPA was measured. BSA-GdDTPA was titrated in approxi-
mately 0.2 mM increments into a into a 1 mL vial containing 1 M
[13C,15N2]urea. At each titration point, the
13C urea T1 was mea-
sured via saturation recovery experiments at B0 = 3 T, T = 27
◦C.
A linear fit was performed on the [BSA-GdDTPA] versus 1/T1 data
points. Using this measured curve in conjunction with model-based
estimates of the rats’ blood volumes, the in vivo T1 of
13C urea
within the blood pool was roughly estimated.
In this study, 4 rats were imaged after 2 separate 13C urea in-
jections: one with the BSA-GdDTPA chaser and one without to
act as the control experiment. Due to the persistence of the BSA-
GdDTPA in the blood pool, the chaser experiment was always
performed after the control. Fig 3a shows a schematic of the ex-
perimental timeline. Rats were injected with 3 mL, 150 mM hy-
perpolarized [13C,15N2]urea solution over 12 s. The hyperpolarized
urea was then allowed to diffuse for 28 s, and the 13C T2 mapping
sequence was initiated 40 s after the beginning of injection. 2
hours later, a second [13C,15N2]urea infusion was performed over
12 s. The hyperpolarized urea was then allowed to diffuse for 20
s, then 1 mL, 0.59 mM BSA-GdDTPA (15 mM GdDTPA) was
injected over 1 s. The chaser was allowed to diffuse for 7 s, and
then the 13C T2 mapping sequence was initiated again 40 s after
the beginning of the urea injection.
Statistical Analysis Image noise was estimated by the standard
deviation of a signal-free region of the 13C images (prior to image
denoising), and all image pixels were normalized by this measure-
ment. All pixels of the 13C urea images with first-time-point-SNR
greater than 10 were included in analysis. Multi exponential cal-
culations were performed on each pixel after image alignment and
denoising. The short- and long-T2 signal components were isolated
from the T2 distributions calculated at each pixel using the inte-
gration limits (α = 0.3 s, β = 2.5 s) for the short-T2 component
and (α = 2.5 s, β = 20 s) for the long-T2 component. In this
way, 4 maps were calculated for each animal: short- and long-T2
signal maps for each 13C urea and 13C urea + BSA-GdDTPA ex-
periment. In each animal, the mean pixel signal of each map was
computed, and two paired t-tests were performed: one comparing
the mean short-T2 SNR of the
13C urea images with and without
BSA-GdDTPA chaser, and the other comparing the mean long-
T2 SNR of the
13C urea images with and without BSA-GdDTPA
chaser. p < 0.05 was used as the significance criteria. Additionally,
all pixels from the short-T2 and long-T2 maps from all 4 animals
were binned by signal intensity and plotted on top of each other
as a aid for visualization of the BSA-GdDTPA chaser effects.
3
1H MRI For a qualitative visualization of the Gd carrier distri-
bution, 1H-detected, T1-weighted images were acquired 5 minutes
post infusion of BSA-GdDTPA. This was followed by an addi-
tional injection of 1 mL, 0.5 mM low molecular weight (940 Da)
Gd-DTPA without attached albumin (Magnevist, Bayer Schering,
Berlin). Both Gd agents were imaged the same 1H spoiled gradi-
ent echo (SPGR) sequence (flip angle = 35, TE/TR = 1.4/7 ms,
3 averages, .8 mm isotropic resolution).
Diuresis / Antidiuresis Relaxometry
13C Imaging Experiments These experiments were designed
to measure the T2 of two agents - hyperpolarized
13C urea and
hyperpolarized 13C HMCP - in response to induced antidiuresis
and osmotic diuresis in rats. In the antidiuresis state, the kidney
is in maximally concentrating mode, and high levels of circulating
vasopressin activate the inner medullary transporters UT-A1 and
UT-A3 in order to maximally concentrate urea while minimizing
water loss. 3 rats were imaged with both agents; HMCP served as
a control since this molecule is not expected to be affected by urea
transporters. The methods for inducing diuresis and antidiuresis
were identical to those described previously [72]. To induce antid-
iuresis, the rats were deprived of food and water for an overnight
period of 16 hours. To induce osmotic diuresis, the rats were first
deprived of food and water for 16 hours and then allowed free
access to aqueous glucose (10% by mass) solution for 9 hours. In
each experiment, the urea injection (3 mL, 150 mM hyperpolarized
[13C,15N2]urea) was performed at least 2 hours prior to the HMCP
injection (3 mL, 125 mM hyperpolarized HMCP). The T2 mapping
sequence was initiated 40 s after the beginning of injection with
identical acquisition parameters aside from a 4.5 kHz resonance
frequency offset between urea and HMCP.
Statistical Analysis Both kidneys were manually delineated
on all 13C images after alignment and denoising, and only pix-
els within the kidney were included in analysis. Following pixel
selection, a T2 distribution was computed for each pixel. A single
mean 〈T2〉 value was calculated at each pixel from this distribution
by calculating the first moment over the full distribution (α = 0.3
s, β = 20 s). The use of the full distribution was motivated by
the difficulty in comparing two molecules with differing relaxation
properties. 4 maps were computed for each of the 3 animals: 〈T2〉
maps for urea and HMCP in diuresis and antidiuresis states. His-
tograms including all pixels binned by 〈T2〉 were plotted for each
agent to visualize the effect of diuresis and antidiuresis states. For
quantitative comparison, the mean of the upper-90th percentile
was computed for each animal. Due to the inward 〈T2〉 gradient
observed with both agents, this operation selected pixels within
the center of the kidney. Two paired t-tests were then performed:
the first compared the mean upper-90th percentile of 〈T2〉 of urea
between diuresis and antidiuresis, and the second compared the
mean upper-90th percentile of 〈T2〉 of HMCP between diuresis and
antidiuresis. p < 0.05 was used as the significance criteria.
1H MRI Animals were imaged in the coronal and axial planes
using a T2-weighted
1H fast spin echo (FSE) sequence with TR =
1s, TE =100 ms, 32 echoes, 0.8 mm in-plane resolution.
High Resolution 13C Imaging Techniques
Multiple Echo Time Averaging The persistence of signal
across multiple echo times allowed for image averaging to increase
the effective SNR. This summation was performed after motion
correction and SV D denoising.
3D Imaging As an alternative multi-exponential fitting, the
MRI acquisition may be designed with a long echo time to fil-
ter out the short-T2 signal components. One method of achieving
this is using 2 spatial dimensions of phase encoding (for the acqui-
sition of a full 3D image) with a rasterized Cartesian ordering in
which the echo time is half the total acquisition time. A 3D SSFP
acquisition was initiated at 20 s, 25 s, and 30 s after the beginning
of urea injection. This sequence used a large flip angle (θ = 120◦)
and extremely long echo time (3.5 s) allowing for editing out the
vascular signal with enhancement of the long-T2 filtrate. The un-
aliased FOV was chosen to cover only the kidneys in the 2 phase
encoded dimensions. Since the images were sampled below the
Nyquist cutoff frequency in these dimensions, the signal filtering
of the ultra long echo time acquisition was utilized to reduce alias-
ing from the vascular signal. A (42, 42, 14) acquisition matrix was
acquired over a (5, 5, 1.7) cm FOV in (L-R,S-I,A-P) coordinates
yielding a 1.2 mm isotropic pixel length. 588 phase encodes were
acquired with TR = 12 ms for a 7 s total scan time.
Results
13C Urea / BSA-GdDTPA Relaxometry
The T1 relaxivity of the BSA-GdDTPA complex on
13C urea was
estimated to be 77 ± 10 mM−1s−1 with respect to the BSA car-
rier, or 3.1 ± .4 mM−1s−1 per GdDTPA chelate (R2 = .97) from
saturation recovery experiments. Fig. 3e shows the measured T1
relaxivity curve with error bars indicating T1 measurement uncer-
tainty from the intrinsic signal to noise ratio. The estimated rat
blood volume was 27±3 mL [44]. Therefore, at the expected in vivo
[BSA-GdDTPA] of ∼ 0.024 mM, the urea T1 should be approxi-
mately 0.5 s. Although this calculation is extremely rough since it
ignores circulation or potentially differing relaxivity in vivo and in
vitro, the 7 s delay should have been adequate for any hyperpolar-
ized 13C urea to undergo several T1 time constants of decay leading
to large polarization loss when in contact with BSA-GdDTPA.
Figure 2 shows a first echo 13C urea image with (Fig. 2a) and
without (Fig. 2b) the chaser injection of the macromolecular BSA-
GdDTPA relaxation agent. This image shows a large suppression
of the vascular 13C urea signal throughout as well as darkening
of the interlobular branches of the renal artery (Fig 2b). The
darkening of the renal arterial branches indicates that the 7 s delay
was adequate not only for both bolus arrival of the BSA-GdDTPA
to the kidneys, but also for the BSA-GdDTPA to cause substantial
13C urea polarization loss. These same arterial branches show up
bright in a T1-weighted
1H image (Fig 2c). No renal perfusion
was detected with the BSA-GdDTPA agent up to 5 minutes after
initial infusion. In contrast, the post-GdDTPA image (Fig 2d)
shows renal perfusion and bladder accumulation since this agent is
freely filtered at the glomerulus [79].
The dynamic 13C urea images acquired under T2 decay condi-
tions initially showed greatly reduced signal at early echo times
4
Figure 2: Differential attenuation of the 13C urea signal
after a chase injection of the intravascular agent BSA-
GdDTPA. Large field-of-view images are shown on the top, and
the bottom panels are zoomed to the kidney. a) First time-point
13C urea MRI image. b) 13C urea MRI acquired 8 s after BSA-
GdDTPA infusion shows strong suppression of the vascular signal
and interlobular arteries (red arrow). c) 1H MRI acquired 5 min-
utes after BSA-GdDTPA infusion. The interlobular arteries show
positive contrast in this image (green arrow). d) 1H MRI acquired
5 minutes after GdDTPA infusion. In contrast to BSA-GdDTPA
(mass ∼ 85 kDa), GdDTA (mass ∼ 938 Da) is freely filtered at the
glomerulus (yellow arrow).
when accompanied by the BSA-GdDTPA chaser. At later echo
times, however, the images converge and look nearly identical.
This effect is most easily visualized in the supplemental video S1:
by the 7th time point (corresponding to a 6.8 s echo time) only
urea within the kidneys is visible in both images, and the signal’s
spatial variation is nearly identical in the images with and without
the BSA-GdDTPA chaser. The similarity persisted in all exper-
iments until the end of imaging acquisition. At this echo time,
both images show urea signal throughout the cortex and medulla,
and a dark-rim is present at the outer stripe of the outer medulla.
The later echo images were acquired up to 25 s after the infusion
of the BSA-GdDTPA chaser and provide strong evidence that the
slowly decaying 13C urea signal component emanated from regions
inaccessible to the BSA-GdDTPA.
Multi exponential relaxometry quantified this dissimilarity at
early echoes and similarity at late echoes. Fig 3b and 3c show
the short-T2 and long-T2 signal components, respectively, with the
latter appearing identical in the 13C urea images with and with-
out BSA-GdDTPA. Fig 3h shows a single decay curve from a pixel
selected from the center of the kidney with semi-log axes. The
two decay modes show up as peaks in the T2 distributions in Fig
3d, with the short-T2 component being significantly reduced by
the BSA-GdDTPA chaser. Binning the all the pixels from all an-
imals scanned also clearly showed this differential attenuation of
the short- and long-T2 signal components (Fig. 4a, 4b). The mean
of the short- and long-T2 components for the 4 animals is shown
Figure 3: 13C urea T2 relaxometry after quenching the vas-
cular signal. a) Timeline of the substrate injections and imaging.
The left column shows images from the control experiment, and
the center column shows the post BSA-GdDTPA images. b) 13C
urea signal outside of the kidneys has T2 less than 2.5 s which
was strongly attenuated by BSA-GdDTPA. c) The long-T2 urea
signal component was confined to the kidneys and was unaffected
by the BSA-GdDTPA chaser. d) T2 distributions of single pixels
selected from the center of the kidneys showing this short-T2 sig-
nal attenuation (red arrow). e) The 13C urea relaxation rate 1/T1
decreases linearly with BSA-GdDTPA concentration with a slope
of 77 ± 10 mM−1s−1. f) T1 weighted 1H imaging 5 minutes post
BSA-GdDTPA infusion. g) T1 weighted
1H imaging post GdDTPA
infusion. h) Single pixel T2 decay curves (corresponding to the dis-
tributions in d).
in the box plot in Fig. 4c. The whiskers represent the minimum
and maximum of the mean of the short- and long-T2 maps. The
paired t-test showed significant (p < .05) diminishing of the SNR
of the short-T2
13C urea signal component over all animals.
Diuresis / Antidiuresis Relaxometry
Fig. 5 shows the long-T2, extravascular
13C urea. During osmotic
diuresis, the urea remains largely in the outer medulla and cortex
at the imaging start time used (40 s after the beginning of a 12
5
Figure 4: 13C urea T2 relaxometry after quenching the vas-
cular signal. Pixel distributions of the short-T2 (a) and long-T2
(b) of the 13C urea signal with and without BSA-GdDTPA chaser.
All pixels with first time point SNR > 10 from 4 animals are dis-
played in these histograms. c) shows the range of the mean of
these signal components for the 4 animals scanned. A paired t-
test show significant (p < 0.05) attenuation of the short-T2 by the
BSA-GdDTPA chaser (shown in the left 2 boxes).
s injection). During antidiuresus, a larger fraction of the urea is
collected in the inner medulla and papilla consistent with the en-
hanced inner-medullary urea pool during antidiuresis indicative if
the UT-A1 and UT-A3 transporters (Fig 5, left). When the acqui-
sition delay allowed for inner-medullary urea accumulation, large
T2 increases were observed due to a strong inward T2 gradient were
observed with the long-T2 component of
13C urea (for example, see
Fig 10 for a T2 distribution of the extravascular
13C urea). Given
this T2 gradient, relaxometry is a sensitive detection method for
observing urea transporter facilitated concentrating ability. Sup-
plementary video S2 shows the dynamic 13C urea at multiple echo
times. During antidiuresis, not only is a greater inner medullary
accumulation of the 13C urea observed, but the signal persists to
very late echo times.
Figure 5: Extravascular 13C urea during antidiuresis and
diuresis. A larger fraction of the urea is collected in the inner
medulla and papilla consistent with the enhanced inner-medullary
urea pool during antidiuresis indicative if the UT-A1 and UT-A3
transporters (left). During diuresis, the urea is primarily in the
cortex and outer medulla (right) at the time of imaging.
Fig. 6 shows T2 exponential relaxometry performed with both
imaging agents in rats on induced diuresis and antidiuresis. Rather
than selecting the short- or long-T2 components, the mean 〈T2〉
Figure 6: Hyperpolarized 13C urea and HMCP relaxome-
try during antidiuresis and diuresis. Hyperpolarized 13C urea
and HMCP images are shown the left and right columns, respec-
tively. HMCP showed increased medullary T2 but the effect did
not vary between diuresis (b) and antidiuresis (a) states. c) decay
curves selected from a single pixel in the inner medulla. The red
arrow shows the persistence of signal to late echo times.
(calculated by equation 3 with α = 0.3 s, β = 20 s) was used
to simplify analysis. A large 〈T2〉 increase was observed in the
inner medulla and renal papilla with 13C urea during antidiuresis
(Fig. 6a). This 〈T2〉 increase in the kidneys’ central region was
not observed in diuresis (Fig. 6b). The signal distribution and
〈T2〉 of HMCP did not change significantly between antidiuresis
and diuresis (Fig. 6a,b, right). This effect can also be seen in the
pixel histogram 〈T2〉 distributions (selected from pixels within the
kidney) in Figure 7.
Both agents showed 〈T2〉 lengthening in the inner medulla and
papilla. Unlike 13C urea, HMCP showed a small 〈T2〉 reduction in
the cortex and outer medulla compared to the blood. HMCP had
a much higher 〈T2〉 in the vascular pool (4 s) compared to urea (1
s). This effect is most easily visualized in the outer margins of the
images in Fig. 6a,b (right). With 13C urea, 〈T2〉 values greater
than 2 s were only observed within the kidney.
High Resolution 13C Imaging Techniques
After image alignment, denoising, and echo time averaging, signal
in the ureters could be observed in osmotic diuresis conditions
with both 13C urea and HMCP (see Fig 8). The inner lumen of
the rat ureter has a diameter between 50 and 150 µm [24], so a 1
mm width pixel (acquired perpendicular plane to the ureter axis)
contains on the order of 10 nL intra-ureter fluid. Although the
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Figure 7: Pixel 〈T2〉 distributions of 13C urea and HMCP re-
laxometry during diuresis and antidiuresis. a) 13C urea and
b) HMCP pixels from the kidneys of 3 animals. The distribution
extends to high 〈T2〉 values for 13C urea in antidiuresis indicating
13C urea concentration in the inner medullary collecting ducts and
medullary interstitium. This effect was not observed with HMCP.
c) the mean upper 90th percentile plotted for all animals.
signal was extremely faint, the persistence of signal allowed for
detectable ureter structure. HMCP had a much stronger signal
than 13C urea in the ureters likely due to its longer T1. Ureters
were only visible in 2 of the 3 diuresis scans for HMCP and 1 of 3
scans for 13C urea. The long T1 of HMCP enabled urinary bladder
collection to be imaged at over 3 minutes post injection (image not
shown).
Figure 8: 13C ureter imaging during diuresis. 10 echo times
(from 5 s to 14 s) were averaged after alignment and denoising to
improve signal. Ureters could be observed in diuresis with both
urea and HMCP (arrows). High urea reabsorption and reduced
UT-A1 and UT-A3 activity leads to substantial cortical and outer
medullary signal compared to HMCP.
Fig. 9 shows 3D images acquired at 1.2 mm isotropic resolution
(1.73 mm3 pixel volume). These images are zoomed to a single
kidney. The efficacy of the blood pool suppression is evidenced
by the low background signal as well as the dark interlobular ar-
teries (magenta arrows on the image panels). The outer stripe of
the outer medulla (OSOM) enhanced later than the cortex and
inner stripe of the outer medulla (ISOM, see the 20 s and 25 s
time points). Once inner medullary accumulation occurred, the
inner medulla (IM) and papilla were bright due to the sequence
weighting (see simulations in Fig 9a, right). These images high-
light the sensitivity in rats of imaging timing for desired contrast
agent distribution. These images also represent, to the authors’
best knowledge, the first in vivo hyperpolarized 13C images ac-
quired at sub-2 mm3 isotropic resolution.
Figure 9: 13C urea imaging at sub-2 mm3 isotropic reso-
lution a) Sequence design (left) and signal simulations (right 3
panels) of a 1.7 mm3 isotropic resolution image. Simulations show
the signal response expected from regions with T2 = 1.3 s (vascu-
lar pool), T2 = 4 s (cortex / outer medulla), and T2 = 10 s (inner
medulla / papilla). Blue arrows indicate sequence parameters used,
and thus the signal response expected in the images. b) The long
effective echo time (4 s) of a 3D acquisition was utilized for blood
pool signal suppression and for encoding the 13C urea at 1.2 mm
isotropic resolution. b) 13C urea images acquired at three different
delay times after three different injections. Blood pool suppression
is evidenced by the dark interlobular arteries visible on both the
13C urea and 1H fast spin echo images (magenta arrows).
Discussion
Comparison of 1H and 13C MRI of the Kidney Hyperpo-
larized 13C MRI is a background-free imaging method that allows
direct detection the labeled contrast agent in the kidney, whereas
Gd-enhanced 1H MRI utilizes the enhanced relaxation rate of wa-
ter for indirect detection. The latter method, therefore, always
has signal contribution from regions without contrast agent, but
this contribution is typically minimized with strong T1 weighting
of the acquisition. The experiments in this study highlight that
relaxation is also an extremely important factor for the analysis
of hyperpolarized 13C images. Regions of hypo-intense signal may
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stem not only from low contrast agent concentration, but may also
arise from T1 or T2 shortening, and this effective contrast can be
exacerbated by the acquisition.
In both hyperpolarized 13C and Gd-enhanced 1H MRI, the
molecular label carrier influences the renal contrast agent distri-
bution. Since GdDTPA is not significantly reabsorbed along the
nephron [8, 45], the signal likely arises primarily from the lumen
of the tubules and collecting ducts as well as the glomerular blood
supply. A significant fraction of urea in the filtrate, however, is
reabsorbed along the nephron. Fig. 8 shows qualitatively the high
reabsorption of urea compared to HMCP in rats on induced di-
uresis. Urea (mass ∼ 63 Da) and HMCP (mass ∼ 110 Da) are
both freely filtered at the glomerulus, but the late echo time urea
image (Fig 8, bottom left) still shows substantial cortical signal. It
is worth noting that other commonly used endogenous molecular
probes for hyperpolarized 13C MRI such as pyruvate and lactate
are also freely filtered but are nearly completely reabsorbed un-
der normal conditions [1, 25], so significant collection in the inner
medulla and renal pelvis would not be expected. Urea is an en-
dogenous metabolic waste product, and HMCP is a non endoge-
nous molecule, so the kidney attempts to excrete both of these
agents.
Figure 10: T2 of extravascular
13C urea T2-weighted
1H local-
izer is shown on the left. The right image is a T2 map isolated
to the renal filtrate (T2 > 2.5 s). The cortex (C) and inner stripe
of the outer medulla (ISOM) gave lower T2 values than the outer
stripe of the outer medulla (OSOM) and inner medulla (IM). These
T2 variations are potentially indicative of slow
13C urea exchange
between the medullary interstitial fluid and the vasa recta.
The spatial variation of 13C 〈T2〉 is compared with a T2-weighted
spin echo 1H MRI in Fig. 10. In this figure, the mean 〈T2〉 was cal-
culated to represent that of the extravascular urea pool (T2 > 2.5
s). The 1H T2 correlates well with water content [39] and increases
with edema [26], while 13C urea undergoes a strong relaxation
enhancement from erythrocytes [62]. Unlike contrast-enhanced
imaging with GdDTPA which is not significantly reabsorbed, the
extravascular urea signal likely arises from the tubular lumen as
well as the interstitial fluid (IF) due to high permeability along
the proximal tubule, the thin limbs of the loop of Henle, and the
inner-medullary collecting ducts [41, 49]. The relative contribu-
tion of tubular and interstitial pools on the short timescale of the
13C imaging experiment is unknown, but the spatial 〈T2〉 varia-
tion (Fig. 10, right) could suggest a large contribution from the
IF. The cortex (C) and inner stripe of the inner medulla (ISOM)
showed 〈T2〉 values less than the outer stripe of the outer medulla
(OSOM) and inner medulla (IM). A potential explanation is the
urea exchange between the medullary interstitium and the per-
itubular microvascular supply. Urea within the IF is in exchange
with the vasa recta, a process which is critical for efficiency of
the countercurrent exchange mechanism. The density of the per-
itubular vascular network differs within the various renal segments.
The peritubular vascular tissue fraction in the cortex and ISOM is
nearly double that of the OSOM and IM [14, 38]. The medullary
microvascular blood supply is sparse, receives less than 1% of the
total renal blood flow [22], and occupies less than 0.4% of the total
tissue volume [14]. However, the vasa recta are highly permeable
to urea, and the apparent 〈T2〉 lengthening of the 13C urea iso-
lated to the filtrate in the sparse miscrovascular regions (OSOM,
IM) and shortening in the dense microvascular regions (C, ISOM)
potentially indicate that the T2 variations observed indicate a slow
exchange of urea between the interstitium and the microvascular
supply.
Comparison with prior hyperpolarized 13C NMR mea-
surements The 13C urea T1 relaxivity of the macromolecu-
lar relaxation BSA-GdDTPA measured here (3.1 ± .4 mM−1s−1
per GdDTPA, B0 = 3 T) is more than an order of magnitude
higher than that reported with Gadodiamide and [1-13C]pyruvate
(0.19± .01 mM−1s−1, B0 = 4.7 T) [69]. This is likely attributable
to the increased relaxivity from the slow correlation time of the
macromolecule Gd carrier [74] but may also signify some preferen-
tial binding of urea to albumin.
Based on measurements in this and prior studies, 13C urea (with
15N labeling) experiences strong relaxation enhancement in plasma
(T2 = 11 s) and whole blood (T2 = 5 s) compared to aqueous so-
lution (T2 = 24 s) [62]. Although the strongest in vitro relaxation
enhancement was observed in whole blood, this value is more than
double that measured in vivo (T2 = 1.2 s) potentially indicating
a large decrease in the apparent T2 due to flow. Relaxation en-
hancement in erythrocytes is likely due to a combination of high
blood viscosity and high erythrocyte membrane permeability [4];
the latter is mediated by the erythrocyte isoform of the urea trans-
porter UT-B. A 20% reduction in the diffusion coefficient of urea
has been reported in UT-B expressed tissue xenografts compared
to controls likely indicating an increased intracellular pool size [56].
Controlled experiments in erythrocytes reported a changes in the
resonant frequency [57] and reduction of the longitudinal T1 re-
laxation time [54] of the intracellular 13C urea. These results are
concordant with a shortening of the vascular T2 due to erythrocyte
permeability.
The vascular T2 of HMCP measured here (T2 = 4 s at B0 =
3 T) is in agreement with a ”worst case” value (T2 = 1.3 s at
B0 = 2.35 T) reported previously using SSFP [70] but is over an
order of magnitude higher than in vivo measurements (T2 = 0.4
s at B0 = 9.4 T) reported using adiabatic refocusing pulses with
surface coils [34] suggesting further study in the dependence of
apparent T2 measurements on B0, contrast agent uptake in tissue,
and acquisition type.
Experimental Limitations Multicomponent T2 relaxometry
has well-known difficulties in accurately resolving closely-spaced
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T2 values at the SNR, scan times, and echo spacing permissible
on clinical MRI scanners [20]. In this study, the SNR limitation
was somewhat exacerbated by the polarization loss from T1 de-
cay during the long delay periods between injection and imaging
necessary for renal contrast agent accumulation. The observed T2
decay times were significantly longer than those typical of in vivo
1H MRI which permitted the coarse temporal sampling required
by the single-shot, 1 mm resolution planar readout. Furthermore,
T2 differences between intra- and extravascular
13C urea differed
by a factor of at least 4. Decreasing the resolution would allow
finer temporal sampling and increased SNR for the stabilization of
T2 distribution estimation [20]. T2 values less than the sampling
time of 910 ms are not expected to be resolved accurately. In non-
selective in vivo CPMG experiments performed after infusion of
hyperpolarized 13C urea with finer temporal sampling (10 ms), we
observed approximately 30% of the total signal had a T2 of 300 ms
or less.
In each experiment, the rat was given two 3 mL injections of
hyperpolarized contrast agents spaced at least 2 hours apart. For
the macromolecular relaxation experiments, the rat was given 2
additional 1 mL injections of Gd contrast. The total injected vol-
ume equals approximately 1/4 the animals’ total blood volume
and had an unknown affect on cardiac output, glomerular filtra-
tion rate (GFR), and renal concentrating capacity. Additionally,
the urea mixture contained glycerol which, in large doses, is known
to cause GFR reduction in rats [46]. Although it is difficult to con-
clude that this large aggregate injection volume had no transient
effect on renal function, we did not observe imaging evidence of
differing renal concentrating capacity with repeat injections when
the imaging was started at a constant duration after the injection.
Polarization variability will lead to random errors in comparing
absolute SNR between experiments. Although prior measurements
showed less than a 15% variability in 13C urea polarizations when
polarization and transport time are kept consistent [62], this po-
tential random error will almost certainly be minimized with the
use of automated transport injectors [6] and magnetically shielded
transport pathways [51].
Systematic errors may arise in quantitative T2 mapping due
to transmitter strength mis-calibrations when using the transient
phase of the SSFP signal. As derived by Scheffler, the exponential
decay envelope of the signal is described by the positive eigen-
value [66]
λ1 =
1
2
(
(E1 − E2) cos θ +
√
4E1E2 + (E1 − E2)2 cos2 θ
)
, (4)
with E1 = e
−TR/T1, E2 = eTR/T2 . The transmitter offset may be
modeled as θ = 180◦ + δθ, and a Taylor expansion of λ1 gives
λ1 ≈ a0 + a1δθ + a2δθ2 + ... (5)
with
a0 = E2 (6)
a1 = 0 (7)
a2 =
E2 (E1 − E2)
E1 + E2
(8)
Non-ideal pi pulses will cause some apparent lengthening of the
measured T2 by introducing some T1 weighting. However, these
errors show up only as second or higher even order terms of δθ. The
second order term is minimized when E1 ≈ E2, and this condition
is expected to be better approximated in the longer T2 regions.
Assuming T2 = 1.5 s, T1 = 20 s, flip angle errors δθ/θ up to 20%
cause the apparent decay time to differ from T2 by less than 10%.
Potential Clinical Utility Although T2-weighted imaging has
been a standard clinical MRI evaluation for three decades [23],
only a few studies have investigated T2 contrast for in vivo hyper-
polarized 13C agents imaging [35, 62, 78]. In addition to chemical
shift [19, 29, 42, 61, 68, 76] and diffusion [35, 37, 40, 56, 67] sensitive
imaging techniques, T2 relaxometry could be a very useful tool for
probing the microenvironment of hyperpolarized 13C molecules in
vivo since it yields high signal thus allowing for high resolution
encoding.
Given the importance of urea in the urine concentrating mech-
anism, high resolution imaging of renal urea handling could be a
powerful tool for the investigation of renal physiology. This imag-
ing technique could be applicable to the monitoring diuretic drugs
which act on urea transporters [12,65,77] or to study the effects of
antineoplastic drugs whose side effects include reduced urea con-
centrating ability [63]. Radiologically, this method could address
the inherent difficulty of renal perfusion evaluation on patients with
impaired renal function and chronic kidney disease since virtually
all commonly used iodinated CT contrast agents and gadolinium-
based MRI contrast agents pose some hazard of acute renal failure
in these patients [52, 55]. Although urea clearance is well known
to be an inaccurate marker for GFR estimation due to its signifi-
cant reabsorption [49], 13C urea MRI could provide a qualitative
assessment of renal perfusion such as is regularly performed on
transplantation candidates, before and after ablation for renal cell
carcinoma, and for the assessment of congenital urological abnor-
malities [15, 58, 79]. All experiments in this study were performed
on a clinical MRI scanner using infused urea doses which have been
shown to be safe for humans with far advanced renal failure [28].
Conclusion
High resolution imaging of two key steps of the renal urea han-
dling process was enabled by a hyperpolarized 13C relaxometry.
Selective quenching of the vascular hyperpolarized 13C signal with
a macromolecular relaxation agent revealed that a long-T2 compo-
nent of the 13C urea signal originated from the renal extravascular
space, thus allowing the vascular and filtrate pools of the 13C urea
to be distinguished via multi-exponential analysis. The T2 response
to induced diuresis and antidiuresis was performed with two imag-
ing agents: hyperpolarized 13C urea and a control agent hyper-
polarized bis-1,1-(hydroxymethyl)-1-13C-cyclopropane-2H8. Large
T2 increases in the inner-medullar and papilla were observed with
the former agent and not the latter during antidiuresis suggesting
that T2 relaxometry may be used to monitor the inner-medullary
urea transporter (UT)-A1 and UT-A3 mediated urea concentrat-
ing process. Two high resolution imaging techniques - multiple
echo time averaging and ultra-long echo time sub-2 mm3 resolu-
tion 3D imaging - were developed to exploit the particularly long
relaxation times observed.
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